← Back to browse
S 272 Passed a chamber

Requires infant formula manufacturers to report confirmed positive microbial test results to the Food and Drug Administration within one business day, and requires the agency to report on infant formula supply chains and safety for five years.

Official title: Protect Infant Formula from Contamination Act

Next stop House: awaiting action
Timeline each lane is a chamber; dates pull from congress.gov actions
House
Received 04-MAY-2026
Senate
Introduced 28-JAN-2025
Referred 28-JAN-2025
Approved by committee 15-JAN-2026
Reported 28-JAN-2026
On the calendar 28-JAN-2026
Passed 28-APR-2026
Key points
  • Requires manufacturers to notify the Secretary of Health and Human Services within one business day of a confirmed positive test for a required microorganism, even if the product has already left their facility.
  • Requires manufacturers to isolate affected product as the Secretary directs, stop distribution if required, and provide isolates or whole genome sequence data.
  • Requires the Secretary to respond to manufacturers within one business day and to confirm within 90 days that an appropriate investigation and corrective action are underway.
  • Requires a progress report within 180 days on the FDA's 2025 infant formula supply strategy, quarterly supply chain reports for five years, and supply adequacy reports at 1, 3, and 5 years.
AI-generated from the Engrossed in Senate text of 28-APR-2026 · verify · report an error
Official CRS summary

Covers an older version. The newest CRS summary describes the bill as of "Introduced in Senate" (28-JAN-2025); the text has changed since (Engrossed in Senate, 28-APR-2026).

CRS is the Library of Congress's nonpartisan research office. Read it on congress.gov
Committee referrals (1) Policy area

Health

Sponsor Gary C. Peters (D-MI) Cosponsors · 9
■ 6 D■ 3 R